Cargando…
Correction: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
Autores principales: | Moore, R Andrew, Derry, Sheena, Makinson, Geoffrey T, McQuay, Henry J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526572/ http://dx.doi.org/10.1186/ar1866 |
Ejemplares similares
-
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2005) -
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2008) -
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
por: Moore, R Andrew, et al.
Publicado: (2008) -
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006) -
Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction
por: Moore, R Andrew, et al.
Publicado: (2005)